Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Frontiers in Microbiology|May 2, 2022
Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late PresentersMafalda N S Miranda, Marta Pingarilho, Victor Pimentel, et al.
Iscience|December 28, 2020
CD32<sup>+</sup>CD4<sup>+</sup> memory T cells are enriched for total HIV-1 DNA in tissues from humanized micePhilipp Adams, Virginie Fievez, Rafaëla Schober, et al.
Nature Communications|May 12, 2016
A microfluidics-based in vitro model of the gastrointestinal human-microbe interfacePranjul Shah, Joëlle V Fritz, Enrico Glaab, et al.
Plos One|September 7, 2016
The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell TransmissionEveline Santos da Silva, Martin Mulinge, Morgane Lemaire, et al.
Plos One|May 14, 2013
HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected]Martin Mulinge, Morgane Lemaire, Jean-Yves Servais, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 17, 2019
Multicenter evaluation of the cobas® HIV-1 quantitative nucleic acid test for use on the cobas® 4800 system for the quantification of HIV-1 plasma viral loadPhillip Adams, Ellen Vancutsem, Cyrielle Nicolaizeau, et al.
Viruses|January 20, 2021
Molecular Epidemiological Analysis of the Origin and Transmission Dynamics of the HIV-1 CRF01_AE Sub-Epidemic in BulgariaIvailo Alexiev, Ellsworth M Campbell, Sergey Knyazev, et al.
Immunotargets and Therapy|September 12, 2025
Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast CancerCarole Seguin-Devaux, Bianca Brandus, Jean-Marc Plesseria, et al.
International Journal of Molecular Sciences|December 18, 2019
Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1'-<i>O</i>-isopropyl ether Shows Improved Selectivity Against the Epstein-Barr Virus Lytic CycleMáté Vágvölgyi, Gábor Girst, Norbert Kúsz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 7, 2021
Validation of molecular clock inferred HIV infection ages: Evidence for accurate estimation of infection datesEvangelia Georgia Kostaki, Stefanos Limnaios, Sotirios Roussos, et al.
Pageof 8